Cargando…
PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431479/ http://dx.doi.org/10.1097/01.HS9.0000851668.47673.be |
| _version_ | 1784780067072638976 |
|---|---|
| author | Frölich, L. Blumenberg, V. Rejeski, K. Schmidt, C. Winkelmann, M. Schöberl, F. von Baumgarten, L. Kunz, W. Bücklein, V. Subklewe, M. |
| author_facet | Frölich, L. Blumenberg, V. Rejeski, K. Schmidt, C. Winkelmann, M. Schöberl, F. von Baumgarten, L. Kunz, W. Bücklein, V. Subklewe, M. |
| author_sort | Frölich, L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431479 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94314792022-08-31 PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT Frölich, L. Blumenberg, V. Rejeski, K. Schmidt, C. Winkelmann, M. Schöberl, F. von Baumgarten, L. Kunz, W. Bücklein, V. Subklewe, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431479/ http://dx.doi.org/10.1097/01.HS9.0000851668.47673.be Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Frölich, L. Blumenberg, V. Rejeski, K. Schmidt, C. Winkelmann, M. Schöberl, F. von Baumgarten, L. Kunz, W. Bücklein, V. Subklewe, M. PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT |
| title | PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT |
| title_full | PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT |
| title_fullStr | PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT |
| title_full_unstemmed | PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT |
| title_short | PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT |
| title_sort | pb2210: favorable outcome after second cd19 car t infusion of an identical product: host environment and disease characteristics determine the outcome of treatment |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431479/ http://dx.doi.org/10.1097/01.HS9.0000851668.47673.be |
| work_keys_str_mv | AT frolichl pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT blumenbergv pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT rejeskik pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT schmidtc pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT winkelmannm pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT schoberlf pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT vonbaumgartenl pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT kunzw pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT buckleinv pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment AT subklewem pb2210favorableoutcomeaftersecondcd19cartinfusionofanidenticalproducthostenvironmentanddiseasecharacteristicsdeterminetheoutcomeoftreatment |